Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Other Non-Current Liabilities (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $484000.0 as the latest value for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 36.4% year-over-year to $484000.0; the TTM value through Dec 2025 reached $484000.0, down 36.4%, while the annual FY2025 figure was $484000.0, 36.4% down from the prior year.
  • Other Non-Current Liabilities was $484000.0 for Q4 2025 at Day One Biopharmaceuticals, down from $761000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $761000.0 in Q4 2024, with the low at $484000.0 in Q4 2025.